| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.003 | 1 |